HK$21.18
0.00%
Hong Kong, Oct 30, 09:30 am HKT.
ISIN
CNE100004QP1
Symbol
2252

Shanghai Microport Medbot-h Stock price

HK$21.18
+0.00 0.00% 1M
-10.84 33.85% 6M
-3.12 12.84% YTD
-5.94 21.90% 1Y
+4.44 26.52% 3Y
-24.62 53.76% 5Y
-24.62 53.76% 10Y
-24.62 53.76% 20Y
Hong Kong, Closing price Mon, Nov 02 2026
+0.00 0.00%
ISIN
CNE100004QP1
Symbol
2252

AI Insights on Shanghai Microport Medbot-h Insights AI Insights on Shanghai Microport Medbot-h

How does the company make money?
Who are the company’s main competitors?

Is Shanghai Microport Medbot-h a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,100 stocks worldwide.

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
positive
Cash
HK$750.0m
Shares outstanding
1.0b
Valuation
P/E
negative
P/S | estimate
- | -
EV/Sales | estimate
- | -
EV/FCF | ex SBC
- | -
P/B
-
Financial Health
Equity Ratio
30.8%
Return on Equity
-60.8%
ROCE
-18.6%
ROIC
-265.0%
Debt/Equity
1.0
Share-Based Compensation & Dilution
SBC | % of Revenue
HK$49.7m | 7.7%
SBC as % of FCF
-
SBC Growth 1Y
-12.4%
Share Count Growth 1Y
2.5%
Shareholder Yield
-2.5%
Financials
Revenue | estimate
HK$649.5m | HK$1.4b
EBITDA
-
EBIT
HK$-193.7m
Net Income
HK$-294.2m
Free Cash Flow | ex SBC
HK$-29.9m | HK$-79.6m
Growth
Revenue | estimate
114.2% | 116.7%
EBITDA
-
EBIT
65.4%
Net Income
61.1%
Free Cash Flow
92.5%
Margin
Gross
48.4%
EBITDA
-
EBIT
-29.8%
Net
-45.3%
Free Cash Flow | ex SBC
-4.6% | -12.3%
More
EPS
HK$-0.3
FCF per Share
HK$0.0
Short interest
-
Employees
464
Rev per Employee
HK$1.4m

Shanghai Microport Medbot-h Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Shanghai Microport Medbot-h forecast:

13x Buy
93%
1x Hold
7%

Analyst Opinions

14 Analysts have issued a Shanghai Microport Medbot-h forecast:

Buy
93%
Hold
7%

Financial data from Shanghai Microport Medbot-h

Dec '25
+/-
%
649 649
114% 114%
100%
- Direct Costs 335 335
66% 66%
52%
314 314
209% 209%
48%
- Selling and Administrative Expenses 294 294
5% 5%
45%
- Research and Development Expense 255 255
30% 30%
39%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT -194 -194
65% 65%
-30%
Net Profit -294 -294
61% 61%
-45%

In millions HKD.

Don't miss a Thing! We will send you all news about Shanghai Microport Medbot-h directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, manufacturing, and sale of surgical robots. The company is headquartered in Shanghai, Shanghai and currently employs 464 full-time employees. The company went IPO on 2021-11-02. The firm's business covers the fields of laparoscopic, orthopedic, panvascular, natural orifice and percutaneous surgical procedures. The firm's products include Toumai LaparoscopicSurgical Robot, Toumai Single-port Laparoscopic Surgical Robot, DFVision Three Dimensions (3D) Electronic Laparoscope, SkyWalker Orthopedic Surgical Robot, Trans-bronchial Surgical Robot, R-ONE Vascular Interventional Robot, and iSR’obot Mona Lisa RoboticTransperineal Prostate Biopsy System. The firm conducts its businesses in domestic and overseas markets.

Head office China
Employees 464
Website www.medbotsurgical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today